FDA issues EUAs for stimulator device, ventilator

Jul 14, 2020 - 03:39 PM
FDA product update

The Food and Drug Administration last week authorized emergency use for a non-invasive nerve stimulator at home or in health care settings to treat suspected COVID-19 patients experiencing worsened asthma-related shortness of breath and reduced airflow. The device from electroCore, Inc. is intended for use when other drug therapies are not tolerated or do not provide enough symptom relief. FDA also authorized as a ventilator a CPAP mask combined with a N95 from Circadiance.

Related News Articles

Headline
FDA to limit COVID-19 vaccine to people over 65, others at high risk for serious illness
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
Study finds driving with COVID-19 raises crash risk by 25%
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
Senate Finance Committee advances RFK Jr. nomination for HHS secretary
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
CDC: Flu activity remains high, COVID-19 increasing while RSV peaks 
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
OSHA ends efforts to establish COVID-19 safety standard 
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
Certain PREP Act liability protections for COVID-19 countermeasures extended through 2029 
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…